Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

All numbers in thousands USD
Period Ending
31 Jan 2026
31 Jan 2025
31 Jan 2024
31 Jan 2023
Total Revenue
215,938,000
130,497,000
60,922,000
26,974,000
Cost of Revenue
--
32,639,000
16,621,000
1,040,000
Gross Profit
215,938,000
97,858,000
44,301,000
15,356,000
Operating Expenses
Research Development
--
--
--
7,339,000
Selling General and Administrative
--
--
--
14,058,000
Non Recurring
--
--
--
--
Others
6,386,000
16,405,000
11,329,000
(10,265,000)
Total Operating Expenses
6,386,000
16,405,000
11,329,000
11,132,000
Operating Income or Loss
130,387,000
81,453,000
32,972,000
4,224,000
Income from Continuing Operations
Total Other Income/Expenses Net
(9,022,000)
(729,000)
237,000
48,000
Earnings Before Interest And Taxes
141,709,000
84,273,000
34,075,000
4,443,000
Interest Expense
--
--
--
--
Income Before Tax
141,450,000
84,026,000
33,818,000
4,181,000
Income Tax Expense
(1,424,000)
11,146,000
4,058,000
(187,000)
Minority Interest
--
--
--
--
Net Income From Continuing Ops
142,874,000
72,880,000
29,760,000
4,368,000
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
(22,807,000)
0
0
0
Net Income
120,067,000
72,880,000
29,760,000
4,368,000
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
120,067,000
72,880,000
29,760,000
7,074,000